Dr. Sharma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-553-8360Fax+1 410-553-8359
Education & Training
- University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 2000 - 2003
- New York Downtown HospitalResidency, Internal Medicine, 1997 - 2000
- Lady Hardinge Medical CollegeClass of 1995
Certifications & Licensure
- MD State Medical License 2010 - 2025
- DC State Medical License 2009 - 2010
- OH State Medical License 2000 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 5 citationsSummary of US Food and Drug Administration Chimeric Antigen Receptor (CAR) T-Cell Biologics License Application Approvals From a Statistical Perspective.Xue Lin, Shiowjen Lee, Poornima Sharma, Bindu George, John Scott
Journal of Clinical Oncology. 2022-10-20 - 20 citationsEnd points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settingsAnn T. Farrell, Julie A. Panepinto, Ankit A. Desai, Adetola A. Kassim, Jeffrey D. Lebensburger
Blood Advances. 2019-12-10 - 32 citationsFDA Approval Summary: Idecabtagene Vicleucel for Relapsed or Refractory Multiple Myeloma.Poornima Sharma, Bindu Kanapuru, Bindu George, Xue Lin, Zhenzhen Xu
Clinical Cancer Research. 2022-05-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: